Logotipo de Valence
populares
Iniciar sesión
Loading data for ABEO — first visit, this takes a few seconds.

Añadir a la lista de seguimiento

Abeona Therapeutics Inc.

NasdaqCM: ABEO · Precio en tiempo real · USD
6.13
-0.03 (-0.49%)
Al cierre: Aug 19, 2026, 8:00 PM
6.13
+0.00%
Fuera de horario: 4:38 PM

Abeona Therapeutics Inc. (ABEO) Stock Price, Analysis & Data

-0.49%

No hay datos disponibles

Precio de compra4.55
Capitalización de mercado350.54M
Ingresos (TTM)25.52M
Beneficio neto (TTM)-62.89M
Beta1.34
EPS (TTM)-1.21
Ratio PER (TTM)n/a
Adelante PE-33.44
P/B (TTM)2.74
P/S (TTM)13.74
Earnings DateNov 11, 2026
Precio de venta7.91
Volumen1,284,987
Volumen medio (20D)1,368,061
Abierto6.31
Anterior Cerrar6.16
Rango del día6.11 - 6.32
Rango de 52 semanas4.00 - 7.65
analistan/a
Precio objetivon/a
Dividendosn/a
Fecha ex dividendon/a

Acerca de ABEO

Abeona Therapeutics Inc., a commercial-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases in the United States. It develops ZEVASKYN, an autologous, cell-based gene therapy for the treatment of patients with recessive dystrophic epidermolysis bullosa. The company also develops ABO-503 to treat X-linked retinoschisis; ABO-504 for the treatment of stargardt disease; and ABO-505 to treat autosomal dominan...

[Leer más]
Industria Biotechnology
Sector Healthcare
IPO Fecha Sep 19, 1980
Empleados 226
Bolsa de Valores NasdaqCM
Símbolo bursátil ABEO
Sitio web https://www.abeonatherapeutics.com
Perfil completo de la empresa

Desempeño financiero

En 2025, los ingresos de Abeona Therapeutics fueron 5.82M, un aumento de undefined% en comparación con 0 del año anterior. Las ganancias fueron 71.18M, una disminución de -211.69%.

Estados financieros

Sorpresa de resultados

Abeona Therapeutics ha publicado sus resultados trimestrales en Aug 13, 2026:
  • Ingresos de $8.72M falla las estimaciones por $0, con Infinity% Crecimiento interanual.
  • EPS de -0.35 falla las estimaciones por -0.11, con 25.53% Crecimiento interanual.

    • Próxima publicación de resultados

    Está previsto que Abeona Therapeutics Inc. publique sus resultados el Nov 11, 2026, antes de que se abra el mercado.
    Los analistas proyectan ingresos de ... Actualizar
    news image

    2 días hace · GuruFocus.com

    Abeona Therapeutics Inc (ABEO) (Q2 2026) Earnings Call Highlights: ZEVASKYN Revenue Surges 31% ...

    Despite manufacturing hiccups and patient cancellations, the company expands its treatment center network and secures CMS NTAP status to bolster market access.

    news image

    5 días hace · Moby

    Abeona Therapeutics Inc. Q2 2026 Earnings Call Summary

    Moby summary of Abeona Therapeutics Inc.'s Q2 2026 earnings call

    news image

    6 días hace · MarketBeat

    Abeona Therapeutics Q2 Earnings Call Highlights

    Abeona Therapeutics (NASDAQ:ABEO) reported second-quarter revenue growth from its ZEVASKYN cell therapy launch while outlining operational challenges involving patient scheduling and manufacturing tha...

    news image

    2 meses hace · Simply Wall St.

    Insider Favorites: Top Growth Companies For June 2026

    Over the last 7 days, the United States market has experienced a 3.3% drop, yet it remains up by 22% over the past year with earnings expected to grow by 17% annually. In this context, identifying gro...

    news image

    2 meses hace · Simply Wall St.

    Top Growth Companies With Insider Ownership In June 2026

    Over the last 7 days, the United States market has experienced a 3.3% decline, yet it remains up by 22% over the past year with earnings anticipated to grow by 17% annually in the coming years. In thi...

    Página 1 de 2